James Stambaugh, VP Clinical Affairs at Intersect ENT, Inc. (XENT), sold 12,000 shares at $30.52 ($366K) on 2015-07-20, disclosed to the SEC on 2015-07-21.
Scheduled sale ($366k) by VP Clinical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XENT | SELL | 2016-07-19 | $77K | — | Filing → |
| XENT | SELL | 2016-06-14 | $7K | — | Filing → |
| XENT | SELL | 2015-05-11 | $66K | — | Filing → |